> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CMS proposes first-ever standing Medicare payment category for AI software
- URL: https://members.americanhealthintel.com/2026-07-28-serviceline/
- Published: 2026-07-28T21:08:14.000Z
- Updated: 2026-07-28T21:08:14.000Z
- Description: Plus: Radiology subspecialties gain 2-3% under CY2027 fee schedule despite conversion factor cut. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: Radiology subspecialties gain 2-3% under CY2027 fee schedule despite conversion factor cut. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Service Line Tuesday, July 28, 2026 CMS proposes first-ever standing Medicare payment category for AI software Plus: Radiology subspecialties gain 2-3% under CY2027 fee schedule despite conversion factor cut. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Rule Confidence: High Medicare regulators just proposed the first-ever standing way to pay for AI software as its own billable service, and imaging and cardiac AI tools make up most of the initial list of 36 codes. CMS's new "Software as a Medical Service" category moves 21 of those codes onto a temporary payment track that holds rates near 2026 levels. A billing identity before a durable price. Comments close August 31, 2026. Why it matters Medicare is for the first time proposing to pay for AI software as its own billable service, which could reshape how hospitals adopt diagnostic AI tools. Watch whether this new category survives into the final rule this fall. Sources: [CMS](https://www.cms.gov/newsroom/fact-sheets/calendar-year-2027-hospital-outpatient-prospective-payment-system-opps-ambulatory-surgical-center?ref=members.americanhealthintel.com) · [Beckerspayer](https://www.beckerspayer.com/financial/cms-floats-new-medicare-payment-category-for-ai-diagnostic-software-6-notes/?ref=members.americanhealthintel.com) · [STAT](https://www.statnews.com/2026/07/16/cms-to-revamp-payments-for-clinical-software-ai/?ref=members.americanhealthintel.com) Rule Confidence: High CMS's 2027 physician fee schedule cuts the base Medicare conversion factor for the fourth year running, but radiology's own math shows most imaging subspecialties still coming out ahead. ACR's summary of the rule projects diagnostic radiology and nuclear medicine up 2%, interventional radiology and radiation oncology up 3%, once practice-expense changes are counted. Comments close September 14, 2026. Why it matters A Medicare rule that looks like a pay cut on its face actually helps most imaging specialties once the underlying cost-allocation math is applied. It is a reminder to read past the headline conversion factor number. Sources: [CMS](https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-medicare-physician-fee-schedule-proposed-rule?ref=members.americanhealthintel.com) · [Auntminnie](https://www.auntminnie.com/practice-management/administration/economics/article/15830122/acr-issues-initial-summary-of-2027-mpfs-proposed-rule?ref=members.americanhealthintel.com) Also today Washington imaging practices settle ransomware class action for $3.3 million [Read](https://americanhealthintel.com/editions/2026-07-28-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#mt-baker-imaging-ransomware-settlement) Radiology AI marketplace CARPL.ai raises $10 million led by the IFC [Read](https://americanhealthintel.com/editions/2026-07-28-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#carpl-ai-series-a-ifc) ROOT Act folded into bipartisan Patients First Act, strengthening its path [Read](https://americanhealthintel.com/editions/2026-07-28-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#root-act-auc-revival-2026) 20-fold: the coming increase in US actinium-225 capacity, still years away [Read](https://americanhealthintel.com/editions/2026-07-28-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#terrapower-ac225-operator-metric) 296Records$19.0BEnforcement12Deadlines91Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-07-28-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |